“Since the beginning of September 2020, CGMP regulations now require all manufacturers of drug products to detect and quantify any methanol present in each lot of alcohol they receive. Assurance of this has most likely been made a high priority for FDA field personnel.”     By Eric Foxman, AAHP readm more…

Read More

By Mark Land, AAHP President A quality drug is consistently safe, effective, and free of contamination or defects. Patients and consumers expect quality drugs with every dose they take. The homeopathic industry monitors the quality of its products, and so too does the U.S. Food and Drug Administration (FDA). Specifically, readm more…

Read More

AAHP’s Board of Directors just completed its fourth annual strategy retreat. Together we reflected on the accomplishments, challenges, and opportunities we’ve had during this truly unprecedented year. Throughout the COVID-19 public health emergency, AAHP delivered on education, regulatory, and community outreach projects. Our Board and committee chairs are working harder readm more…

Read More

In support of our member company MediNatura, Inc. challenging FDA’s attack on its prescription injectable homeopathic products, AAHP filed an amicus brief in the United States District Court for the District of Columbia on Aug. 28. On June 11, 2020 FDA sent warning letters to AAHP members MediNatura and Hevert readm more…

Read More